tiprankstipranks
Bausch ‘win’ in Xifaxan case clears major hurdle ahead of spin, says Jefferies
PremiumThe FlyBausch ‘win’ in Xifaxan case clears major hurdle ahead of spin, says Jefferies
14d ago
Appeals court affirms ruling in Bausch Health-Norwich patent fight
PremiumThe Fly
Appeals court affirms ruling in Bausch Health-Norwich patent fight
14d ago
Bausch Health announces ARAZLO availability through BC PharmaCare
PremiumThe Fly
Bausch Health announces ARAZLO availability through BC PharmaCare
14d ago
Bausch Health files patent lawsuit against Amneal Pharmaceuticals
PremiumThe FlyBausch Health files patent lawsuit against Amneal Pharmaceuticals
20d ago
Bausch Health call volume above normal and directionally bullish
PremiumThe Fly
Bausch Health call volume above normal and directionally bullish
20d ago
Bausch Health price target raised to $12 from $9 at RBC Capital
PremiumThe Fly
Bausch Health price target raised to $12 from $9 at RBC Capital
20d ago
Bausch Health price target raised to $7 from $6 at BofA
PremiumThe FlyBausch Health price target raised to $7 from $6 at BofA
2M ago
Bausch Health sees 2024 revenue $9.3B-$9.55B, consensus $9.02B
PremiumThe Fly
Bausch Health sees 2024 revenue $9.3B-$9.55B, consensus $9.02B
2M ago
Bausch Health reports Q4 EPS (11c), consensus $1.02
PremiumThe Fly
Bausch Health reports Q4 EPS (11c), consensus $1.02
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100